- –World market, 2023
- –Projected, 2033
- –Growth a year (CAGR)
- –Active clinical trials worldwide
Abuse Deterrent Opioids by country and region
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
Philippines
Russia
Saudi Arabia
Singapore
South Africa
Spain
Thailand
UAE
UK
US"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 74 papers since 2021
- Model-Informed Drug Development (MIDD) for Analgesics: Review of Applications, Regulatory Integration, and Emerging Directions. Journal of pain research, 2026
- HME as a transformative platform in pharmaceutics: from molecular dispersion engineering to personalized drug delivery. International journal of pharmaceutics, 2026
- Purdue's development of abuse-deterrent formulation opioids as a response to market competition: An industry documents analysis. SSM. Qualitative research in health, 2026
- Evaluation of Abuse Deterrent Formulations of Oxycodone Products: Real-World Data from an Enriched Population of Substance Users Assessed with the Addiction Severity Index-Multimedia Version (ASI-MV(®)). Journal of pain research, 2026
- Development, optimization, and in vitro assessment of abuse-deterrent formulation. Journal of opioid management, 2026
Key companies in Abuse Deterrent Opioids
Purdue Pharma
Teva Pharmaceuticals
Collegium Pharmaceutical
Pfizer
Inspirion Delivery Technologies
Egalet
Acura Pharmaceuticals
Quick answers
How much research is published on Abuse Deterrent Opioids?
PubMed lists about 74 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.